Journal of Clinical Medicine (May 2024)

Intrauterine Infusion and Hysteroscopic Injection of Autologous Platelet-Rich Plasma for Patients with a Persistent Thin Endometrium: A Prospective Case–Control Study

  • Tzu-Ning Yu,
  • Tsung-Hsien Lee,
  • Maw-Sheng Lee,
  • Yi-Chun Chen,
  • Chung-I Chen,
  • En-Hui Cheng,
  • Pin-Yao Lin,
  • Chun-Chia Huang,
  • Chun-I Lee

DOI
https://doi.org/10.3390/jcm13102838
Journal volume & issue
Vol. 13, no. 10
p. 2838

Abstract

Read online

Objectives: To evaluate the effect of intrauterine infusion and hysteroscopic injection of autologous platelet-rich plasma (PRP) in patients with a persistent thin endometrium (EM) undergoing euploid frozen embryo transfer (EFET) cycles. Methods: This prospective case–control study enrolled 116 infertile women with thin EM (Results: After receiving intrauterine infusion and hysteroscopic injection of PRP, 78.2% and 55.3% of patients, respectively, showed an EM thickness exceeding 7 mm, followed by embryo transfer. The hysteroscopic injection group demonstrated significantly higher IR (52%), a higher trend of CPR (52%), and a higher live birth rate (38%) than the control group (18%, 22%, and 4%). Conclusions: Intrauterine infusion and hysteroscopic injection of autologous PRP may be effective methods to increase EM thickness in HRT cycles. According to our results, both methods could increase EM thickness, while hysteroscopic injection appeared to provide more significant assistance in increasing IR, CPR, and live birth rate after EFET in patients with persistent thin EM.

Keywords